Ana Teresa Freitas

Amministratore Delegato presso HeartGenetics, Genetics & Biotechnology SA

Commercial Services

Profilo

Ana Teresa Freitas is associated with HeartGenetics, Genetics & Biotechnology SA as the Chief Executive Officer since 2013.
She is the founder of the company, which was also founded in 2013.

Posizioni attive di Ana Teresa Freitas

Società	Posizione	Inizio
HeartGenetics, Genetics & Biotechnology SA HeartGenetics, Genetics & Biotechnology SA Miscellaneous Commercial ServicesCommercial Services HeartGenetics, Genetics & Biotechnology SA operates as a biotech company that develops genetic tests and computational tools designed to support clinical diagnosis and the prevention of cardiovascular diseases. Its genetic testing kits include Clopidogrel PGX, TromboGene Kit, Warfarin PGX, Simvastatin PGX, and DNArterial Kit. The company was founded by Ana Teresa Freitas and Susana Santos in April 2013 and is headquartered in Cantanhede, Portugal.	Amministratore Delegato	01/04/2013

Tutte le posizioni attive di Ana Teresa Freitas

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ana Teresa Freitas

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
HeartGenetics, Genetics & Biotechnology SA HeartGenetics, Genetics & Biotechnology SA Miscellaneous Commercial ServicesCommercial Services HeartGenetics, Genetics & Biotechnology SA operates as a biotech company that develops genetic tests and computational tools designed to support clinical diagnosis and the prevention of cardiovascular diseases. Its genetic testing kits include Clopidogrel PGX, TromboGene Kit, Warfarin PGX, Simvastatin PGX, and DNArterial Kit. The company was founded by Ana Teresa Freitas and Susana Santos in April 2013 and is headquartered in Cantanhede, Portugal.	Commercial Services